$38.46
-0.66[-1.69%]
At close: Apr 25
$38.46
0[0.00%]
After Hours: 4:20PM EDT
Halozyme Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Halozyme Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | HALO | Q1 | $0.47 | $0.76 | — | — | $162.14M | $212.15M | — | — | Get Alert |
02/20/2024 | PM | HALO | Q4 | $0.48 | $0.83 | $0.82 | -1.20% | $181.50M | $233.19M | $230.04M | -1.35% | Get Alert |
11/06/2023 | PM | HALO | Q3 | $0.74 | $0.73 | $0.75 | 2.74% | $208.98M | $222.63M | $216.03M | -2.96% | Get Alert |
08/08/2023 | PM | HALO | Q2 | $0.53 | $0.63 | $0.74 | 17.46% | $152.37M | $199.32M | $221.04M | 10.90% | Get Alert |
05/09/2023 | PM | HALO | Q1 | $0.47 | $0.48 | $0.47 | -2.08% | $117.28M | $175.51M | $162.14M | -7.62% | Get Alert |
02/21/2023 | PM | HALO | Q4 | $0.42 | $0.47 | $0.48 | 2.13% | $102.00M | $192.05M | $181.50M | -5.50% | Get Alert |
11/08/2022 | PM | HALO | Q3 | $0.55 | $0.51 | $0.74 | 45.10% | $115.83M | $191.10M | $208.98M | 9.35% | Get Alert |
08/09/2022 | PM | HALO | Q2 | $0.66 | $0.50 | $0.53 | 6.00% | $136.46M | $138.78M | $152.37M | 9.79% | Get Alert |
05/10/2022 | PM | HALO | Q1 | $0.37 | $0.49 | $0.47 | -4.08% | $89.02M | $128.25M | $117.28M | -8.55% | Get Alert |
02/22/2022 | PM | HALO | Q4 | $0.50 | $0.41 | $0.42 | 2.44% | $121.70M | $100.32M | $102.00M | 1.68% | Get Alert |
11/02/2021 | PM | HALO | Q3 | $0.31 | $0.42 | $0.55 | 30.95% | $65.32M | $101.94M | $115.83M | 13.63% | Get Alert |
08/09/2021 | PM | HALO | Q2 | $0.19 | $0.40 | $0.66 | 65.00% | $55.22M | $103.16M | $136.46M | 32.28% | Get Alert |
05/10/2021 | PM | HALO | Q1 | -$0.04 | $0.32 | $0.37 | 15.62% | $25.35M | $84.88M | $89.02M | 4.88% | Get Alert |
02/23/2021 | PM | HALO | Q4 | -$0.24 | $0.53 | $0.50 | -5.66% | $53.66M | $120.16M | $121.70M | 1.28% | Get Alert |
11/02/2020 | PM | HALO | Q3 | -$0.17 | $0.20 | $0.25 | 25.00% | $46.23M | $60.91M | $65.32M | 7.23% | Get Alert |
08/10/2020 | PM | HALO | Q2 | -$0.10 | $0.25 | $0.19 | -24.00% | $39.15M | $66.68M | $55.22M | -17.19% | Get Alert |
05/11/2020 | PM | HALO | Q1 | $0.01 | -$0.02 | -$0.04 | -100.00% | $56.95M | $42.96M | $25.35M | -40.98% | Get Alert |
02/24/2020 | PM | HALO | Q4 | -$0.01 | -$0.15 | -$0.24 | -60.00% | $60.23M | $56.93M | $53.66M | -5.74% | Get Alert |
11/12/2019 | PM | HALO | Q3 | -$0.19 | -$0.12 | -$0.17 | -41.67% | $25.56M | $54.81M | $46.23M | -15.65% | Get Alert |
Halozyme Therapeutics (HALO) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 20, 2024 for Q4.
The Actual EPS was $0.82, which missed the estimate of $0.83.
The Actual Revenue was $230M, which missed the estimate of $233.2M.
Browse earnings estimates, EPS, and revenue on all stocks.